Biomarker Analysis & Drug Discovery

Measuring complex biomarkers like NO (nitric oxide) and H2O2 (hydrogen peroxide) in a laboratory setting can be costly and time-consuming, requiring expensive instrumentation and expertise. Our advanced chemiluminescent technology provides significant advantages over traditional in-vitro imaging modalities and gold standard methods, making analysis more cost-effective and time-efficient.

Committed to providing our clients the most advanced, selective biomarker analysis solutions available, BioLum offers a range of services for drug discovery, therapeutic R&D, and basic research to meet diverse needs. We specialize in detection of reactive oxygen, nitrogen, and sulfur species (RONSS). Our state-of-the-art lab capabilities and sensitive chemical technology enable high-selectivity testing relevant across a spectrum of disease states and patient populations.

Customized Solutions for Every Client

We work with you to understand your specific requirements. Our solutions can be tailored across a range of biomarkers found in different specimens including plasma, serum, blood, condensate, and living cells to demonstrate concentration, dose dependency, drug efficacy, and other factors.

Comprehensive R&D

As a service provider, every step we take aims to unveil new pathways to treatment and understanding the intricate world of fundamental biomarkers, underscoring our commitment to novel therapeutic discovery, health innovation, and disease prevention. Explore a partnership where technology, expertise, and precision converge for transformative breakthroughs.